371
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Hypothalamic–pituitary–adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters

, , &
Pages 575-581 | Received 11 Jan 2016, Accepted 17 Apr 2016, Published online: 23 May 2016

References

  • Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372–81.
  • Goldstein RB, Black DW, Nasrallah A, Winokur G. The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry 1991;48:418–22.
  • Richard-Devantoy S, Gorwood P, Annweiler C, Olie JP, Le Gall D, Beauchet O. Suicidal behaviours in affective disorders: a deficit of cognitive inhibition? Can J Psychiatry 2012;57:254–62.
  • Keilp JG, Gorlyn M, Russell M, Oquendo MA, Burke AK, Harkavy-Friedman J, et al. Neuropsychological function and suicidal behavior: attention control, memory and executive dysfunction in suicide attempt. Psychol Med 2013;43:539–51.
  • Liu RT, Miller I. Life events and suicidal ideation and behavior: a systematic review. Clin Psychol Rev 2014;34:181–92.
  • Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, et al. Toward a biosignature for suicide. Am J Psychiatry 2014;171:1259–77.
  • Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:677–736.
  • Nowacka M, Obuchowicz E. BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep 2013;65:535–46.
  • Dwivedi Y. Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 2010;42:87–96.
  • Grah M, Mihanovic M, Ruljancic N, Restek-Petrovic B, Molnar S, Jelavic S. Brain-derived neurotrophic factor as a suicide factor in mental disorders. Acta Neuropsychiatr 2014;26:356–63.
  • Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 2010;13:535–9.
  • Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011;14:347–53.
  • Chatzittofis A, Nordstrom P, Hellstrom C, Arver S, Asberg M, Jokinen J. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters. Eur Neuropsychopharmacol 2013;23:1280–7.
  • Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, et al. Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 2012;136:350–8.
  • Tripodianakis J, Markianos M, Sarantidis D, Leotsakou C. Neurochemical variables in subjects with adjustment disorder after suicide attempts. Eur Psychiatry 2000;15:190–5.
  • Brunner J, Stalla GK, Stalla J, Uhr M, Grabner A, Wetter TC, et al. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J Psychiatr Res 2001;35:1–9.
  • Pompili M, Serafini G, Innamorati M, Moller-Leimkuhler AM, Giupponi G, Girardi P, et al. The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci 2010;260:583–600.
  • Jokinen J, Nordstrom P. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 2008;33:1387–93.
  • Jokinen J, Nordstrom AL, Nordstrom P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord 2008;106:145–52.
  • Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001;158:748–53.
  • Coryell W, Young E, Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res 2006;142:99–104.
  • Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 2006;4:465–74.
  • Suri D, Vaidya VA. Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neurosci 2013;239:196–213.
  • Issa G, Wilson C, Terry AV Jr, Pillai A. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol Dis 2010;39:327–33.
  • Pluchino N, Russo M, Santoro AN, Litta P, Cela V, Genazzani AR. Steroid hormones and BDNF. Neurosci 2013;239:271–9.
  • Goel N, Workman JL, Lee TT, Innala L, Viau V. Sex differences in the HPA axis. Compr Physiol 2014;4:1121–55.
  • Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 2014;220:223–50.
  • Finsterwald C, Alberini CM. Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem 2014;112:17–29.
  • Lindqvist D, Nimeus A, Traskman-Bendz L. Suicidal intent and psychiatric symptoms among inpatient suicide attempters. Nord J Psychiatry 2007;61:27–32.
  • Beck AT, Davis J, Frederick, CJ, Perlin S, Pokorny A, Schulman R, et al. Classification and nomenclature. In: Resnik HPL, Hathorne B (eds). Suicide Prevention in the Seventies. Washington, DC: US Government Printing Office; 1972.
  • American Psychiatric Association. Diagnostics and Statistical Manual of Mental Disorders. 3rd Edition rev. Washington, DC: American Psychiatric Association; 1987.
  • Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 1978;271:5–27.
  • Zhang J, Zhang X, Su H, Tao J, Xie Y, Han B, et al. Increased serum brain-derived neurotrophic factor levels during opiate withdrawal. Neurosci Lett 2014;571:61–5.
  • Heberlein A, Lenz B, Muschler M, Frieling H, Buechl R, Groschl M, et al. BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence. Psychopharmacology 2010;209:213–5.
  • Bayard-Burfield L, Alling C, Blennow K, Jonsson S, Traskman-Bendz L. Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 1996;6:195–9.
  • Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, et al. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 1993;33:129–33.
  • Lindqvist D, Traskman-Bendz L, Vang F. Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders. Arch Suicide Res 2008;12:197–207.
  • Bender R, Lange S. Adjusting for multiple testing-when and how? J Clin Epidemiol 2001;54:343–9.
  • Rojas PS, Fritsch R, Rojas RA, Jara P, Fiedler JL. Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study. Psychiatry Res 2011;189:239–45.
  • Kunugi H, Hori H, Adachi N, Numakawa T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 2010;64:447–59.
  • Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116–27.
  • Hansson AC, Sommer W, Rimondini R, Andbjer B, Stromberg I, Fuxe K. c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J Neurosci 2003;23:6013–22.
  • Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768–77.
  • Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 2009;12:73–82.
  • Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006;9:519–25.
  • Schrijvers DL, Bollen J, Sabbe BG. The gender paradox in suicidal behavior and its impact on the suicidal process. J Affect Disord 2012;138:19–26.
  • Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005;26:115–23.
  • Hayley S, Du L, Litteljohn D, Palkovits M, Faludi G, Merali Z, et al. Gender and brain regions specific differences in brain derived neurotrophic factor protein levels of depressed individuals who died through suicide. Neurosci Lett 2015;600:12–6.
  • Lindqvist D, Isaksson A, Traskman-Bendz L, Brundin L. Salivary cortisol and suicidal behavior-a follow-up study. Psychoneuroendocrinology 2008;33:1061–8.
  • Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex differences in response to stress and expression of depressive-like behaviours in the rat. Curr Top Behav Neurosci 2011;8:97–118.
  • Bath KG, Schilit A, Lee FS. Stress effects on BDNF expression: effects of age, sex, and form of stress. Neurosci 2013;239:149–56.
  • Toufexis D, Rivarola MA, Lara H, Viau V. Stress and the reproductive axis. J Neuroendocrinol 2014;26:573–86.
  • Kim YK, Lee HP, Won SD, Par EY, Lee HY, Lee BH, et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:78–85.
  • Greenberg ME, Xu B, Lu B, Hempstead BL. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 2009;29:12764–7.
  • Sodersten K, Palsson E, Ishima T, Funa K, Landen M, Hashimoto K, et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord 2014;160:1–9.
  • Ceulemans DL, Westenberg HG, van Praag HM. The effect of stress on the dexamethasone suppression test. Psychiatry Res 1985;14:189–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.